Xiao-Ming Mao
Quick facts
Marketed products
- MMI · Neurology
MMI is a selective monoamine oxidase B (MAO-B) inhibitor. - MMI combined with IID
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: